Literature DB >> 25176624

From chromosomal abnormalities to the identification of target genes in mouse models of breast cancer.

Victoria T Fabris1.   

Abstract

Cytogenetic studies of breast cancer cells have identified numerous chromosomal imbalances, including gains in human chromosome regions 1q, 4p, 8q, and 20q and losses in regions 1p, 3p, 6q, 11q, 16q, 17p, and 22q. Mouse models have been developed to study the mechanisms of mammary carcinogenesis, and in most cases, the corresponding karyotypes have been reported. Here, I summarize the cytogenetic findings and the candidate genes that are involved in mammary tumorigenesis. The most commonly altered chromosomes in mouse breast cancer models are chromosomes 4 and 11, which are orthologous to human chromosomes that are also affected by chromosomal abnormalities in human breast cancer. The genes that are affected by chromosomal imbalances in mouse models have also been found to participate in human breast cancer. In addition, the amplification and overexpression of several new genes in mouse models have subsequently been confirmed in human breast cancer. In this review, I compile information on the available karyotypes for mouse breast cancer models.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; carcinogenesis; cytogenetics; karyotype; mouse model

Mesh:

Year:  2014        PMID: 25176624     DOI: 10.1016/j.cancergen.2014.06.025

Source DB:  PubMed          Journal:  Cancer Genet


  7 in total

1.  Association of CCND1 Gene c.870G>A Polymorphism with Breast Cancer Risk: A Case-ControlStudy and a Meta-Analysis.

Authors:  Zahra Soleimani; Davood Kheirkhah; Mohammad Reza Sharif; Alireza Sharif; Mohammad Karimian; Younes Aftabi
Journal:  Pathol Oncol Res       Date:  2016-12-21       Impact factor: 3.201

2.  Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16q.

Authors:  Brian Pedro; Manali Rupji; Bhakti Dwivedi; Jeanne Kowalski; Jessica M Konen; Taofeek K Owonikoko; Suresh S Ramalingam; Paula M Vertino; Adam I Marcus
Journal:  Cancer       Date:  2020-04-21       Impact factor: 6.860

Review 3.  The structure and function of NKAIN2-a candidate tumor suppressor.

Authors:  Shan-Chao Zhao; Bo-Wei Zhou; Fei Luo; Xueying Mao; Yong-Jie Lu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 4.  Breast cancer animal models and applications.

Authors:  Li Zeng; Wei Li; Ce-Shi Chen
Journal:  Zool Res       Date:  2020-09-18

5.  The landscape of chromosomal aberrations in breast cancer mouse models reveals driver-specific routes to tumorigenesis.

Authors:  Uri Ben-David; Gavin Ha; Prasidda Khadka; Xin Jin; Bang Wong; Lude Franke; Todd R Golub
Journal:  Nat Commun       Date:  2016-07-04       Impact factor: 14.919

6.  Association between Cyclin D1 G870A (rs9344) polymorphism and cancer risk in Indian population: meta-analysis and trial sequential analysis.

Authors:  Nisha Thakur; Suchitra Kumari; Ravi Mehrotra
Journal:  Biosci Rep       Date:  2018-11-30       Impact factor: 3.840

7.  A Transcriptome-Level Study Identifies Changing Expression Profiles for Ossification of the Ligamentum Flavum of the Spine.

Authors:  Yawei Han; Yuheng Hong; Liandong Li; Tengshuai Li; Zhen Zhang; Jingzhao Wang; Han Xia; Yutao Tang; Zhemin Shi; Xiaohui Han; Ting Chen; Qi Liu; Mengxia Zhang; Kun Zhang; Wei Hong; Yuan Xue
Journal:  Mol Ther Nucleic Acids       Date:  2018-08-07       Impact factor: 8.886

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.